Neos Therapeutics Inc. (NEOS) Soars 6.22% on March 13

Neos Therapeutics Inc. (NEOS) Soars 6.22% on March 13

Neos Therapeutics Inc. (NEOS) had a good day on the market for Wednesday March 13 as shares jumped 6.22% to close at $2.22. About 296,480 shares traded hands on 1,455 trades for the day, compared with an average daily volume of n/a shares out of a total float of 49.68 million. After opening the trading day at $2.13, shares of Neos Therapeutics Inc. stayed within a range of $2.27 to $2.06.

With today’s gains, Neos Therapeutics Inc. now has a market cap of $110.28 million. Shares of Neos Therapeutics Inc. have been trading within a range of $9.25 and $1.40 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

Neos Therapeutics Inc is a pharmaceutical company, engaged in the development, manufacture, and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies. The product portfolio of the company includes Methylphenidate XR-ODT and Amphetamine XR oral suspension commonly prescribed medicine for the treatment of ADHD. In addition, it also manufactures and markets generic Tussionex, a hydrocodone polistirex and chlorpheniramine polistirex XR liquid suspension product indicated for the relief of cough. Geographically, it operates through United States and derives revenue through sale of products.

Neos Therapeutics Inc. is based out of Grand Prairie, TX and has some 138 employees.

Share:
Scroll Up
error: Content is protected !!